Spexis AG (SPEXN)

Currency in CHF
0.01
0.00(0.00%)
Closed·
Showing Spexis historical data. For real-time data please try another search
Day's Range
0.010.01
52 wk Range
0.010.07
Key Statistics
Bid/Ask
0.04 / 0.05
Prev. Close
0.06
Open
0.01
Day's Range
0.01-0.01
52 wk Range
0.01-0.07
Volume
-
Average Volume (3m)
524.66K
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Spexis AG Company Profile

Spexis AG operates as a biopharmaceutical company focused on discovering and developing macrocyclic molecules for rare diseases and cancer. The company develops and markets macrocyclic molecule-based therapeutics, including ColiFinR, an inhaled therapeutic for cystic fibrosis that is approved and marketed in Europe, with plans for further global studies. It maintains two macrocycle libraries, Pemfinder and Macrofinder, for drug discovery targeting various molecular targets, and has several pre-clinical leads for different indications. The company seeks development, commercialization, strategic transaction, and financial partnerships for its rare disease and oncology programs. Spexis serves investors, development and commercialization partners, and other firms in the biotechnology and pharmaceutical sectors, as well as financial and strategic transaction partners within the life sciences industry. The company is based in Allschwil, Switzerland.

Employees
50
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Jun 01, 2024
EPS / Forecast
-0.28 / --
Revenue / Forecast
349.24K / --
EPS Revisions
Last 90 days

SPEXN Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.